Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of the Yekaterinburg Research Institute of Viral Infections Vector, Alexander Semyonov said on the Vesti FM radio station.
"This vaccine [EpiVacCorona] works against all strains that exist, that are known at the moment, including the British, South American and South African ones," he said.
Semyonov said should new coronavirus strains emerge, it would be possible to promptly modify the vaccines accordingly. "In this respect EpiVacCorona, just like Sputnik V, is a quickly 'readjustable' vaccine," TASS cited him as saying.
He noted that EpiVacCorona will be able to protect the vaccinated at least for one year.
EpiVacCorona, developed at the State Research Center of Virology and Biotechnology Vector under the consumer rights watchdog Rospotrebnadzor, was a second vaccine to have been certified in Russia. This happened on October 14, 2020. About one month later the developers were allowed to carry out post-registration research, including tests in aged people.